MGMT and glioblastoma: In this study, we demonstrate that a three-miRNA signature, with an oncosuppressive function in GBM [13], has a sensitizing action towards TMZ, reducing cell proliferation and viability upon treatment in GBM neurospheres, particularly in those with an unmethylated-MGMT status that display a major basal resistance to this drug.